Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Gilead Licenses Long-Acting HIV Prevention Drug
Gilead signs deals with 6 generic drugmakers to sell HIV drug in low-income countries
Gilead Sciences said on Wednesday it has granted royalty-free licenses to six generic drug manufacturers to make and sell cheaper copycat versions of its HIV prevention medicine in 120 low and lower-middle income countries.
Gilead Licenses Long-Acting HIV Prevention Drug to Generics Firms
Gilead Sciences Inc. said it is licensing its twice-yearly experimental HIV prevention drug lenacapavir to six generics makers after coming under fire from HIV advocates who argued the company was prioritizing profit over patients.
Gilead Partners With Generics Developers to Provide HIV Drug to Low-Income Countries
Gilead Sciences is granting licenses to six companies to produce lenacapavir for pre-exposure prophylaxis, as well as for treating human immunodeficiency virus in heavily pre-treated adults with multidrug-resistant infections.
Gilead strikes voluntary licensing deals in poor countries for its pricey HIV drug
Gilead will license the HIV drug lenacapavir, a twice-yearly injectable, to six generic makers for 120 countries.
Gilead Licenses HIV-prevention Drug To Generic Drugmakers
US pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income countries.
11h
HIV prevention: why a new injectable drug could be such a breakthrough – podcast
HIV expert Linda-Gail Bekker talks to The Conversation Weekly about promising results from a trial of a new drug for HIV ...
Queerty
18h
Rise in HIV diagnoses in UK puts goal of ending transmission by 2030 in “jeopardy”
The Terrence Higgins Trust, the UK’s largest sexual health charity, reacted with concern to the figures. They said they put ...
21h
‘Piss Bandit’ who taunts locals with urine bottles labeled ‘HIV positive’ is California’s number-one menace
The “Piss Bandit” has been leaving full bottles of urine on a street in Pasadena. Some see him as a menace, others a ...
4d
on MSN
Why progress against HIV/AIDS has stalled among Hispanic and Latino Americans
Despite progress made against the HIV/AIDS crisis in the U.S, it has stalled for Hispanic and Latino Americans.
10h
Livesaving HIV drug will be sold cheap in Africa and Asia
US pharma company Gilead struck a deal with six companies, allowing them to make cheaper versions of the drug currently ...
1d
US’s $100 Billion HIV Program Commits to African Manufacturing
The US President’s Emergency Plan for AIDS Relief, which represents the world’s biggest financial commitment to fight a ...
Queerty
2d
Why has progress against HIV stalled among Hispanic & Latino Americans?
There was also a significant drop amongst Black men, of 18%, and across the southern states generally, of 16%. It’s ...
2d
Migrants fuel surge in HIV cases to 15-year high
New HIV diagnoses have hit a 15-year high after a surge in the number of cases among migrants coming to England.
1d
HIV cases soaring among Brits - and here's reason alarm being raised
Heterosexuals living outside of London have seen the largest increase in new HIV infection figures, according to new data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Gilead Sciences
United States
England
Africa
COVID-19
Feedback